// App-Quantinova.ai

: MP58-05 THE LONG-TERM PROGNOSTIC VALUE OF SURVIVIN EXPRESSING CIRCULATING TUMOR CELLS IN PATIENTS WITH HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC)

Researchers

Presenter

  • Gian Maria Busetto

Principal Investigators

  • Francesco Del Giudice

  • Paola Gazzaniga

  • Ettore De Berardinis

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Circulating tumor cells

  • Cluster of differentiation 45

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved